Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gentian violet cation is the active moiety of gentian (crystal) violet—a synthetic triphenylmethane dye with broad-spectrum antimicrobial properties. It acts as an antiseptic and antifungal agent and has been used for over a century in medicine to treat fungal infections (such as oral thrush and skin mycoses), bacterial infections (notably gram-positive bacteria like Staphylococcus species), and occasionally for anti-helminthic or anti-trypanosomal purposes[1][2][4][5][7][10]. The mechanism involves dissociation into positive ions that interact with negatively charged components of microbial cell walls (lipopolysaccharide in bacteria; peptidoglycan; DNA). This interaction leads to cell penetration and DNA binding—disrupting replication and inhibiting cell growth. Gentian violet also acts as a mutagen/mitotic poison by interfering with mitosis. Additional mechanisms include dissipation of membrane potential via increased permeability—leading to respiratory inhibition—and photodynamic action mediated by free radicals[5][8][10]. It is considered effective against many fungi (e.g., Candida spp.), some gram-positive bacteria, but less so against gram-negative organisms[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gentian violet cation.